Jaguar Health
JAGX
$4.22
Share price
-1.63%
Change (1 day)
640.35%
Change (1 year)
Categories
Jaguar Health (JAGX) - P/B ratio
P/B ratio as of June 2024 : 1.80
According to Jaguar Health's latest financial reports the company has a price-to-book ratio of 1.80.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Jaguar Health - P/B ratio (from 2015 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 5.43 | -156% |
| 2022-12-31 | -9.69 | -328.43% |
| 2021-12-31 | 4.24 | -21.47% |
| 2020-12-31 | 5.40 | 400.31% |
| 2019-12-31 | 1.08 | -95.69% |
| 2018-12-31 | 25.0 | 1654.5% |
| 2017-12-31 | 1.43 | -134.91% |
| 2016-12-31 | -4.09 | -198.33% |
| 2015-12-31 | 4.15 | |
| 2014-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Lifevantage LFVN | 3.67 | 104.05% | 🇺🇸 USA |
 Taro Pharmaceutical TARO | 0.9016 | -49.90% | 🇮🇱 Israel |